One trial evaluated patients on metformin at baseline with add-on canagliflozin 100 mg , canagliflozin 300 mg , or sitagliptin 100 mg ; the other trial evaluated patients on metformin and a sulfonylurea at baseline with add-on canagliflozin 300 mg or sitagliptin 100 mg .